1. Home
  2. LSPD vs NEO Comparison

LSPD vs NEO Comparison

Compare LSPD & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightspeed Commerce Inc. Subordinate Voting Shares

LSPD

Lightspeed Commerce Inc. Subordinate Voting Shares

HOLD

Current Price

$8.84

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.13

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSPD
NEO
Founded
2005
2001
Country
Canada
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
LSPD
NEO
Price
$8.84
$8.13
Analyst Decision
Buy
Buy
Analyst Count
15
7
Target Price
$13.40
$11.14
AVG Volume (30 Days)
629.3K
1.6M
Earning Date
02-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.43
$10.63
Revenue Next Year
$11.10
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.34
$4.72
52 Week High
$14.34
$13.74

Technical Indicators

Market Signals
Indicator
LSPD
NEO
Relative Strength Index (RSI) 37.36 28.68
Support Level $8.48 $7.59
Resistance Level $9.71 $8.89
Average True Range (ATR) 0.33 0.44
MACD 0.02 -0.01
Stochastic Oscillator 11.79 14.39

Price Performance

Historical Comparison
LSPD
NEO

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: